Valuation: Makers Laboratories Limited

Market Cap 1.11B 11.56M 10.2M 9.65M 8.75M 16.41M 16.57M 116M 44.62M 566M 43.4M 42.45M 1.82B P/E 2025
10.2x
P/E 2026 33.9x
Enterprise Value 1.05B 10.97M 9.68M 9.16M 8.31M 15.57M 15.73M 110M 42.34M 537M 41.19M 40.29M 1.73B EV / Sales 2025
0.67x
EV / Sales 2026 0.53x
Free-Float
31.45%
Yield 2025 *
-
Yield 2026 -

Last Transcript: Makers Laboratories Limited

1 day-1.33%
1 week+0.51%
Current month-0.40%
1 month-0.40%
3 months+27.15%
6 months+37.17%
Current year+56.96%
1 week 176.05
Extreme 176.05
195.65
1 month 171
Extreme 171
217.5
Current year 112.1
Extreme 112.1
236.55
1 year 109
Extreme 109
236.55
3 years 103.85
Extreme 103.85
236.55
5 years 94
Extreme 94
236.55
10 years 23.2
Extreme 23.2
344.8
Manager TitleAgeSince
Director of Finance/CFO 59 30/10/2017
Compliance Officer - 23/05/2024
Sales & Marketing 54 02/08/2017
Director TitleAgeSince
Director/Board Member 51 11/08/2011
Director/Board Member 52 29/01/2018
Chairman 77 28/03/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.33%+0.51%+42.65%+74.30% 11.56M
-0.01%+1.24%+63.06%+120.55% 1,056B
-1.61%-0.60%+47.32%+71.79% 645B
-1.12%-0.72%+17.98%+76.63% 465B
+0.40%-1.08%+89.97%+45.00% 368B
+0.47%-3.44%+34.94%+41.38% 335B
+0.01%+2.96%+20.93%+29.68% 275B
-0.74%-0.69%+10.40%+12.73% 255B
+1.32%+3.27%+54.63%+57.63% 229B
-0.61%-0.91%+34.33%+101.87% 188B
Average -0.15%+0.40%+41.62%+63.16% 381.58B
Weighted average by Cap. +0.01%+0.30%+46.56%+74.27%

Financials

2025 2026
Net sales 1.21B 12.58M 11.11M 10.51M 9.53M 17.87M 18.04M 126M 48.58M 617M 47.25M 46.22M 1.98B 1.41B 14.68M 12.96M 12.26M 11.12M 20.84M 21.05M 147M 56.68M 719M 55.13M 53.93M 2.31B
Net income 74.91M 781K 689K 652K 591K 1.11M 1.12M 7.82M 3.01M 38.25M 2.93M 2.87M 123M 23.51M 245K 216K 205K 186K 348K 351K 2.45M 946K 12.01M 920K 900K 38.64M
Net Debt 48.19M 502K 443K 419K 380K 713K 720K 5.03M 1.94M 24.61M 1.89M 1.84M 79.19M -56.5M -589K -520K -492K -446K -836K -844K -5.9M -2.27M -28.85M -2.21M -2.16M -92.84M
Logo Makers Laboratories Limited
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Employees
114
Date Price Change Volume
30/09/26 ₹185.45 -1.33% 285
29/09/26 ₹187.95 -0.16% 719
28/09/26 ₹188.25 0.00% 1,007
25/09/26 ₹188.25 +0.67% 170
24/09/26 ₹187.00 +1.36% 1,672
  1. Stock Market
  2. Stocks
  3. MAKERSL Stock